Biocon raises Rs 2,250 crore through Commercial Papers

24 Nov 2022 Evaluate

Biocon has raised Rs 2,250 crore through Commercial Papers (CP) on private placement basis on November 23, 2022. Date of maturity of said Commercial Papers will be February 22, 2023. The company had received approval from board of directors on November 14, 2022 for the same.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

379.30 -0.95 (-0.25%)
17-Feb-2026 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.80
Dr. Reddys Lab 1265.80
Cipla 1346.20
Zydus Lifesciences 911.00
Lupin 2247.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×